NEUROBO PHARMACEUTICALS INC's ticker is NRBO and the CUSIP is 64132R107. A total of 23 filers reported holding NEUROBO PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $237,000 | -46.7% | 493,995 | 0.0% | 0.00% | – |
| Q1 2022 | $445,000 | -26.3% | 493,995 | -0.1% | 0.00% | – |
| Q4 2021 | $604,000 | -67.2% | 494,597 | 0.0% | 0.00% | – |
| Q3 2021 | $1,840,000 | +15.6% | 494,597 | +3.5% | 0.00% | – |
| Q2 2021 | $1,592,000 | -47.1% | 477,918 | -30.2% | 0.00% | – |
| Q1 2021 | $3,011,000 | +2234.1% | 684,312 | +2679.2% | 0.00% | – |
| Q4 2020 | $129,000 | +0.8% | 24,623 | +7.6% | 0.00% | – |
| Q3 2020 | $128,000 | -30.1% | 22,885 | +0.4% | 0.00% | – |
| Q2 2020 | $183,000 | – | 22,787 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Mount Yale Investment Advisors, LLC | 57,425 | $191,000 | 0.02% |
| FNY Investment Advisers, LLC | 10,000 | $33,000 | 0.01% |
| SG3 Management, LLC | 50,000 | $167,000 | 0.01% |
| PITCAIRN CO | 12,351 | $41,000 | 0.00% |
| Ergoteles LLC | 30,800 | $103,000 | 0.00% |
| Advisory Services Network, LLC | 8,550 | $28,000 | 0.00% |
| HRT FINANCIAL LP | 18,759 | $62,000 | 0.00% |
| UBS Group AG | 2,881 | $10,000 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 1,062 | $4,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 320 | $1,000 | 0.00% |